| # | Drug | Count |
|---|---|---|
| 0 | BEVACIZUMAB | 7 |
| 1 | PACLITAXEL | 5 |
| 2 | INTERFERON BETA-1A | 3 |
| 3 | ACETAMINOPHEN | 2 |
| 4 | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | 2 |
| 5 | FINASTERIDE | 2 |
| 6 | FOLIC ACID | 2 |
| 7 | INFLIXIMAB | 2 |
| 8 | LANSOPRAZOLE | 2 |
| 9 | LEVOTHYROXINE SODIUM | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEBENTAFUSP | 2 | 0.0033 |
| 1 | NIVOLUMAB AND RELATLIMAB-RMBW | 1 | 0.0019 |
| 2 | PROPARACAINE HYDROCHLORIDE | 1 | 0.0019 |
| 3 | PEGCETACOPLAN | 1 | 0.0005 |
| 4 | ATOVAQUONE | 1 | 0.0001 |
| 5 | QUININE | 1 | 0.0001 |
| 6 | TESTOSTERONE CYPIONATE | 1 | 0.0001 |
| 7 | INSTALAX POLYETHYLENE GLYCOL 3350 | 1 | 0.0001 |
| 8 | POLYETHYLENE GLYCOL 400 | 1 | 0.0001 |
| 9 | SENNOSIDES | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific gp100 Peptide-HLA-directed CD3 T Cell Engager [EPC] | 2 | 0.0033 |
| 1 | Lymphocyte Activation Gene-3 Blocker [EPC] | 1 | 0.0019 |
| 2 | Antimalarial [EPC] | 1 | 0.0001 |
| 3 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 4 | Non-narcotic Antitussive [EPC] | 1 | 0.0001 |
| 5 | Bile Acid [EPC] | 1 | 0.0000 |
| 6 | Typical Antipsychotic [EPC] | 1 | 0.0000 |
| 7 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 7 | 0.0000 |
| 8 | Complement Inhibitor [EPC] | 2 | 0.0000 |
| 9 | Microtubule Inhibitor [EPC] | 5 | 0.0000 |